Cargando…

Fluoro-substituted cyanine for reliable in vivo labelling of amyloid-β oligomers and neuroprotection against amyloid-β induced toxicity

Alzheimer’s disease (AD) is the most prevalent but still incurable neurodegenerative form of dementia. Early diagnosis and intervention are crucial for delaying the onset and progression of the disease. We herein report a novel fluoro-substituted cyanine, F-SLOH, which exhibits good Aβ oligomer sele...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yinhui, Xu, Di, Sun, Anyang, Ho, See-Lok, Poon, Chung-Yan, Chan, Hei-Nga, Ng, Olivia T. W., Yung, Ken K. L., Yan, Hui, Li, Hung-Wing, Wong, Man Shing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Royal Society of Chemistry 2017
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858019/ https://www.ncbi.nlm.nih.gov/pubmed/29619173 http://dx.doi.org/10.1039/c7sc03974c

Ejemplares similares

Effective Theranostic Cyanine for Imaging of Amyloid Species in Vivo and Cognitive Improvements in Mouse Model
por: Li, Yinhui, et al.
Publicado: (2018)

The Toxicity of Amyloid β Oligomers
por: Zhao, Li Na, et al.
Publicado: (2012)

Breaking the Code of Amyloid-β Oligomers
por: Lesné, Sylvain E.
Publicado: (2013)

The Toxicity and Polymorphism of β-Amyloid Oligomers
por: Huang, Ya-ru, et al.
Publicado: (2020)

Amyloid β-protein oligomers and Alzheimer’s disease
por: Hayden, Eric Y, et al.
Publicado: (2013)

β-Amyloid oligomers in aging and Alzheimer’s disease
por: Zahs, Kathleen R., et al.
Publicado: (2013)

The biogenesis and biology of amyloid β oligomers in the brain
por: Ashe, Karen Hsiao
Publicado: (2020)

Is there a sodium effect in fibrillar amyloid-β oligomers?
por: Horn, Anselm HC, et al.
Publicado: (2014)

Polymorphism of Oligomers of a Peptide from β-Amyloid
por: Pham, Johnny D., et al.
Publicado: (2014)

The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy
por: Sengupta, Urmi, et al.
Publicado: (2016)

The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade
por: Cline, Erika N., et al.
Publicado: (2018)

Amyloid-β breaks brain's neuroprotection
por: Wang, Yunling, et al.
Publicado: (2017)

The Binding of Apolipoprotein E to Oligomers and Fibrils of Amyloid-β Alters the Kinetics of Amyloid Aggregation
por: Garai, Kanchan, et al.
Publicado: (2014)

Liquid–liquid phase separation of amyloid-β oligomers modulates amyloid fibrils formation
por: Gui, Xinrui, et al.
Publicado: (2023)

5-Hydroxycyclopenicillone Inhibits β-Amyloid Oligomerization and Produces Anti-β-Amyloid Neuroprotective Effects In Vitro
por: Zhao, Jiaying, et al.
Publicado: (2017)

Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
por: Mroczko, Barbara, et al.
Publicado: (2018)

Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer’s disease
por: Lee, Ming-Che, et al.
Publicado: (2018)

Amyloid-β Forms Fibrils by Nucleated Conformational Conversion of Oligomers
por: Lee, Jiyong, et al.
Publicado: (2011)

Stability of single and double layer fibrillar amyloid-β oligomers
por: Kahler, Anna, et al.
Publicado: (2013)

Assessing the Effects of Acute Amyloid β Oligomer Exposure in the Rat
por: Wong, Ryan S., et al.
Publicado: (2016)

In vivo induction of membrane damage by β-amyloid peptide oligomers
por: Julien, Carl, et al.
Publicado: (2018)

Doxycycline for Alzheimer’s Disease: Fighting β-Amyloid Oligomers and Neuroinflammation
por: Balducci, Claudia, et al.
Publicado: (2019)

Amyloid β oligomers inhibit growth of human cancer cells
por: Pavliukeviciene, Bozena, et al.
Publicado: (2019)

A dopamine metabolite stabilizes neurotoxic amyloid-β oligomers
por: Cataldi, Rodrigo, et al.
Publicado: (2021)

Nanoscopic insights into the surface conformation of neurotoxic amyloid β oligomers
por: Banchelli, Martina, et al.
Publicado: (2020)

Amyloid β-Oligomers Inhibit the Nuclear Ca(2+) Signals and the Neuroprotective Gene Expression Induced by Gabazine in Hippocampal Neurons
por: Lobos, Pedro, et al.
Publicado: (2023)

Structural conversion of neurotoxic amyloid-β(1–42) oligomers to fibrils
por: Ahmed, Mahiuddin, et al.
Publicado: (2010)

A Foldamer-Dendrimer Conjugate Neutralizes Synaptotoxic β-Amyloid Oligomers
por: Fülöp, Lívia, et al.
Publicado: (2012)

Development of new fusion proteins for visualizing amyloid-β oligomers in vivo
por: Ochiishi, Tomoyo, et al.
Publicado: (2016)

Enhanced neuronal degradation of amyloid-β oligomers allows synapse regeneration
por: Bate, Clive
Publicado: (2015)

Amyloid-β oligomers set fire to inflammasomes and induce Alzheimer's pathology
por: Salminen, Antero, et al.
Publicado: (2008)

Distinct thermodynamic signature of oligomer generation in the aggregation of the amyloid-β peptide
por: Cohen, Samuel I. A., et al.
Publicado: (2018)

Characterization of a Novel Mouse Model of Alzheimer’s Disease—Amyloid Pathology and Unique β-Amyloid Oligomer Profile
por: Liu, Peng, et al.
Publicado: (2015)

Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy
por: Saito, Satoshi, et al.
Publicado: (2017)

Amyloid β-peptides 1–40 and 1–42 form oligomers with mixed β-sheets
por: Baldassarre, Maurizio, et al.
Publicado: (2017)

Cellular Prion Protein Mediates Impairment of Synaptic Plasticity by Amyloid-β Oligomers
por: Laurén, Juha, et al.
Publicado: (2009)

Amyloid-β oligomers link depressive-like behavior and cognitive deficits in mice
por: Ledo, J H, et al.
Publicado: (2012)

Postsynaptic Receptors for Amyloid-β Oligomers as Mediators of Neuronal Damage in Alzheimer’s Disease
por: Dinamarca, Margarita C., et al.
Publicado: (2012)

Rare Individual Amyloid-β Oligomers Act on Astrocytes to Initiate Neuronal Damage
por: Narayan, Priyanka, et al.
Publicado: (2014)

Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer’s Disease
por: Hölttä, Mikko, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1c3jop1039d94lhp0tu23ejiss